Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

Policy and public health: all the decisions we can’t see

January was a bad month for healthcare in China

- PMLiVE

AXON recognised for ‘excellence in wellbeing’ by Great Place to Work

Healthcare comms company wins recognition for second year in a row

The ALS patient journey

Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...

Blue Latitude Health

Equipping your medical affairs teams with solutions to navigate the healthcare landscape

Dr Tyler Ray, OPEN Health Medical Communications

OPEN Health

- PMLiVE

Genentech pays $30m upfront to access Bicycle Therapeutic’s discovery technology

Collaboration will focus on discovery of immuno-oncology therapies

- PMLiVE

Takeda buys coeliac disease partner PvP Biologics after phase 1 win

Deal includes upfront payment plus up to $330m in milestones

- PMLiVE

IMV preps pivotal trials for ovarian cancer T cell therapy

Drug stabilised disease in 79% of 19 evaluable patients

- PMLiVE

Mallinckrodt reaches tentative $1.6bn opioid settlement

Agreement reached with a plaintiff's executive committee

- PMLiVE

Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US

National Institutes of Health initiates trial of experimental drug

- PMLiVE

Can protein degraders unlock ‘undruggable’ drug targets?

Exploring a new and exciting area of small-molecule drug discovery

Introducing Nucleus POLAR™, a state-of-the-art external expert search engine and engagement management tool

Nucleus Global, the largest independent medical communications company in the world, has launched Nucleus POLAR™ - a state-of-the-art external expert search and engagement engine. It uses cutting edge technology to...

Nucleus Global

- PMLiVE

Moderna and GSK advance coronavirus vaccine candidates

Developments come amid rapidly growing cases across the globe

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links